CD79A and bacterial urinary tract infection: Intravaginal immunization with a whole-cell vaccine has been shown to be very promising in the prevention of human urinary tract infection (UTI) [24], [25], increasing total vaginal and urinary IgG and IgA [24], and decreasing the risk of UTI in women [25].